New IDF guidelines raise importance of post-meal glucose control

The International Diabetes Federation (IDF) has published new guidelines on the contribution and impact of post-meal glucose in diabetes disease management at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD) on September 19, 2007
Watch out for more information 

 

43rd EASD Annual Meeting 2007

The Annual Meeting of the European Association for the Study of Diabetes (EASD) 2007 took place in Amsterdam from September, 17th until September, 21st. The programme included State of the Art Lectures, Symposia, Oral and Poster Presentations and many more.
more 

 

New Guidelines on Diabetes, Prediabetes and Cardiovascular Diseases

Two new guidelines on the management of Diabetes, Prediabetes and Cardiovascular Diseases were published recently. The IDF guideline presents best practice care for individuals with prediabetes, as agreed by a panel of internationally respected diabetologists at the 2nd International Congress on Prediabetes and the Metabolic Syndrome. The new ESC-EASD Guidelines were presented at the implementation meeting in Nice end of June.
Watch out for more information 

 

2nd International Congress on Prediabetes and the Metabolic Syndrome

The Congress was held in Barcelona from April 25th till April 28th and provided a platform for presentation of basic and clinical trials research results on novel therapies. On this Congress Bayer Schering Pharma contributed with a Satellite Symposium and Meet the Expert Sessions. Furthermore BSP was present with a booth. more 

 

Entering an exciting era of diabetes and cardiovascular prevention – a new outcome trial with Glucobay

A new outcome trial, sponsored by Bayer HealthCare, will commence in2007 and investigate the effects of the oral antidiabetes drug acarbose (Glucobay® , Bayer HealthCare AG), on preventing recurrent cardiovascular disease (CVD) and type 2 diabetes in individuals with CVD and prediabetes. Details were announced by the co-chairmen of the independent research group at a well attended Bayer HealthCare satellite symposium and press conference during the International Diabetes Federation’s 19th World Diabetes Congress held in Cape Town.
more 

 

What does it really mean to have prediabetes?

People with prediabetes, a state between "normal" and "diabetes," are at risk for developing diabetes, heart attacks and strokes. Learn more about health risks associated with prediabetes.
more 

 

What is the treatment of prediabetes?

Treating prediabetes in an essential part of both reducing the diabetes epidemic and reducing the risk of CVD. Treatment involves lifestyle modification and pharmacological therapy.
more 

 

 

Please note:
This website is addressed to an international audience. It is intended for educational purposes only and is in no way intended as a substitute for professional medical advice, to contradict medical advice given or for medical care of any kind. BAYER cannot guarantee the accuracy of its content or that information presented on this website is appropriate for specific locations, in particular, whether products and services are available in size or to the same conditions.

Please review the Terms of Use before using this website. By using this website, you agree to comply with the Terms of Use.